
Results
2
2 companies
argenx
Market Cap: €47.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€779.80
7D
6.8%
1Y
44.5%
Melexis
Market Cap: €2.2b
Designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle East, Africa, the Asia Pacific, and North and Latin America.
MELE
€55.65
7D
-2.6%
1Y
-1.4%